Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study
Annals of Pediatric Endocrinology & Metabolism · 30.06.2026 · 31 (3) · 178-188
DOI: 10.6065/apem.2550238.119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pediatric Endocrinology & Metabolism, erschienen am 30.06.2026. Verfasst von Ke Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gene Science Pharmaceuticals Co., Ltd..
Abstract (Originalsprache)
Purpose
Polyethylene glycol-recombinant human growth hormone (PEG-rhGH) is the first commercial long-acting rhGH preparation approved in China. This study was designed to assess the efficacy and safety of PEG-rhGH in treating growth hormone deficiency (GHD) during the transition period.
Methods
A prospective, multicenter and single-arm study was performed. The entire study duration spanned 66 weeks, comprising a 2-week trial screening phase, a 12-week dose-adjustment period, and a 52-week PEG-rhGH treatment phase. A total of 10 interviews were conducted over the course of the study. The primary endpoint was change in body composition; secondary endpoints were changes in lumbar bone mineral density (BMD, L1–4) and lean body mass (LBM). Sex- and age-specific equations were developed to adjust body composition z-scores.Results: : A total of 31 subjects were included in this study. Throughout the 64-week therapy with PEG-rhGH, the insulin-like growth factor-1 (IGF-1) standard deviation score (SDS) demonstrated progressive elevation from baseline (-3.07 to -1.38; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Hospital Zhejiang University School of Medicine, Hangzhou, China.
- Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Wuhan Children's Hospital (Wuhan Maternal and Child Health Hospital, Wuhan Women's and Children's Health Care Center), Wuhan, China.
- Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. ssy10926@rjh.com.cn.
Förderung
- Gene Science Pharmaceuticals Co., Ltd.
Zitieren
APA
Huang, K., Lin, H., Chen, L., Dong, Z., Li, Y., Li, G., Yao, H., Sun, S., & Fu, J. (2026). Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study. Annals of Pediatric Endocrinology & Metabolism, 31(3), 178-188. https://doi.org/10.6065/apem.2550238.119
Vancouver
Huang K, Lin H, Chen L, Dong Z, Li Y, Li G, et al. Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study. Annals of Pediatric Endocrinology & Metabolism. 2026;31(3):178-188. doi:10.6065/apem.2550238.119
BibTeX
@article{Huang2026,
author = {Huang, Ke and Lin, Hu and Chen, Lifen and Dong, Zhiya and Li, Yanhong and Li, Guimei and Yao, Hui and Sun, Shouyue and Fu, Junfen},
title = {Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study},
journal = {Annals of Pediatric Endocrinology & Metabolism},
year = {2026},
volume = {31},
number = {3},
pages = {178--188},
doi = {10.6065/apem.2550238.119}
}
EUVIMED